Fatty Acid-Binding Protein 4 as a Biomarker for Remission of Type 2 Diabetes

被引：0
|
作者：
Stentz, Frankie B.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-1610-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1610-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Hong Wang
    Jie Cao
    Jian-bin Su
    Xue-qin Wang
    Xing Wang
    Dong-mei Zhang
    Xiao-hua Wang
    Diabetology & Metabolic Syndrome, 13
  • [22] Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Wang, Hong
    Cao, Jie
    Su, Jian-bin
    Wang, Xue-qin
    Wang, Xing
    Zhang, Dong-mei
    Wang, Xiao-hua
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [23] Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes
    Noah Gruber
    Moran Rathaus
    Idit Ron
    Rinat Livne
    Sharon Sheinvald
    Ehud Barhod
    Rina Hemi
    Amit Tirosh
    Orit Pinhas-Hamiel
    Amir Tirosh
    Diabetologia, 2022, 65 : 366 - 374
  • [24] Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes
    Gruber, Noah
    Rathaus, Moran
    Ron, Idit
    Livne, Rinat
    Sheinvald, Sharon
    Barhod, Ehud
    Hemi, Rina
    Tirosh, Amit
    Pinhas-Hamiel, Orit
    Tirosh, Amir
    DIABETOLOGIA, 2022, 65 (02) : 366 - 374
  • [25] Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes
    Rodriguez-Calvo, Ricardo
    Girona, Josefa
    Rodriguez, Marina
    Samino, Sara
    Barroso, Emma
    de Gonzalo-Calvo, David
    Guaita-Esteruelas, Sandra
    Heras, Mercedes
    van der Meer, Rutger W.
    Lamb, Hildo J.
    Yanes, Oscar
    Correig, Xavier
    Llorente-Cortes, Vicenta
    Vazquez-Carrera, Manuel
    Masana, Lluis
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 96 : 12 - 21
  • [26] Circulating adipocyte fatty acid-binding protein levels predict the development of subclinical atherosclerosis in type 2 diabetes
    Xiao, Yang
    Xiao, Xiaoyu
    Xu, Aimin
    Chen, Xiaoyan
    Tang, Weili
    Zhou, Zhiguang
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (12) : 1100 - 1104
  • [27] Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care
    Doi, Kent
    Noiri, Eisei
    Sugaya, Takeshi
    CURRENT OPINION IN CRITICAL CARE, 2010, 16 (06) : 545 - 549
  • [28] Heart-type fatty acid-binding protein as a potential biomarker of acute carbon monoxide poisoning
    Erenler, Ali Kemal
    Yardan, Turker
    Baydin, Ahmet
    Gunay, Murat
    Amanvermez, Ramazan
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (08): : 1165 - 1169
  • [29] Associations between Fatty Acid-Binding Protein 4-A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus
    Trojnar, Marcin
    Patro-Malysza, Jolanta
    Kimber-Trojnar, Zaneta
    Leszczynska-Gorzelak, Bozena
    Mosiewicz, Jerzy
    CELLS, 2019, 8 (03)
  • [30] Urinary liver-type fatty acid-binding protein change in gestational diabetes mellitus
    Fu, Wen-Jin
    Wang, Du-Juan
    Deng, Ren-Tang
    Huang, Zhi-Hong
    Chen, Mei-Lian
    Jang, You-Ming
    Wen, Shu
    Yang, Hong-Ling
    Huang, Xian-zhang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) : E36 - E38
12345